ALDRICH Brand
Displaying 17901-17950 of 68959 results.
Sigma Cat.No. | Description |
---|---|
904554 | DMT-2′O-TBDMS-rC(ac)-3-15N phosphoramidite ≥98 atom % 15N, ≥95% (CP) |
904562 | DMT-2′O-TBDMS-rC(ac)-1,3-15N2 phosphoramidite ≥98 atom % 15N, ≥95% (CP) |
904570 | DMT-2′O-TBDMS-rC(ac)-6-13C,5-d phosphoramidite ≥98 atom % 13C, ≥98 atom % D, ≥95% (CP) |
904597 | DMT-2′O-TBDMS-rU-6-13C,5-d phosphoramidite ≥98 atom % D, ≥98 atom % 13C, ≥95% (CP) |
90460 | Triethylenetetramine ≥97.0% (T) |
904600 | DMT-2′O-TBDMS-rU-1,3-15N2 phosphoramidite ≥98 atom % 15N, ≥95% (CP) |
904619 | DMT-2′O-TBDMS-rU-3-15N phosphoramidite ≥98 atom % 15N, ≥95% (CP) |
904627 | DMT-2′O-TBDMS-rG(ac)-8-13C phosphoramidite ≥98 atom % 13C, ≥95% (CP) |
904635 | DMT-2′O-TBDMS-rG(ac)-1-15N phosphoramidite ≥98 atom % 15N, ≥95% (CP) |
904643 | Thiol functionalized gelatin |
904651 | (S,R,S)-AHPC-PEG3-azide ≥95% |
904678 | Pomalidomide- |
904686 | Pomalidomide-C6-PEG3-butyl azide ≥95% |
904694 | Ir(p-CF3-ppy)3 ≥95% |
904708 | Pomalidomide-C6-PEG3-butyl iodide ≥95% |
904716 | (CAAC-Cy)Rh(COD)Cl |
904724 | Pomalidomide-PEG2-butyl iodide ≥95% |
904767 | [Ru(phen)3]Cl2 ≥95% |
904805 | ((S) ≥95% |
904813 | (S,R,S)-AHPC-PEG2-azide |
904848 | 2- ≥95% |
904864 | (S,R,S)-AHPC-PEG6-butyl azide ≥95% |
904880 | Pomalidomide-C6-PEG1-C3-PEG1-butyl azide ≥95% |
904899 | Spiro[9H-fluorene-9,9′-[9H]xanthene]-2,7-diamine |
904937 | 2,6-Bis(N-pyrazolyl)pyridine nickel (II) dichloride ≥95% anhydrous basis |
904945 | [Ru(dmbpy)3](PF6)2 ≥95% |
904953 | [Ru(dtbbpy)3](PF6)2 ≥95% |
904961 | Feng L3-PrPr2 ≥95% |
904996 | Conjugated Polymer Nanoparticles incorporating iron oxide fluorescence λem 680 nm, 100 μg/mL in H2O |
90502 | N,N′-Di-sec-butyl-p-phenylenediamine 95% |
905038 | Conjugated Polymer Nanoparticles incorporating iron oxide fluorescence λem 510 nm, 100 μg/mL in H2O |
905046 | Conjugated Polymer Nanoparticles incorporating iron oxide fluorescence λem 550 nm, 100 μg/mL in H2O |
905054 | Conjugated Polymer Nanoparticles incorporating iron oxide fluorescence λem 475 nm, 100 μg/mL in H2O |
905062 | Perovskite quantum dots oleic acid and oleylamine coated, fluorescence λem 530 nm, 10 mg/mL in toluene |
905070 | [(TEEDA)Ni(o-tolyl)Cl] ≥95% |
905100 | Ir(p-tBu-ppy)3 |
905194 | 10- ≥95% |
905224 | Pomalidomide-PEG6-butyl amine hydrochloride ≥95% |
905232 | (S,R,S)-AHPC-C6-PEG3-butyl amine hydrochloride ≥95% |
905240 | (R,R,R)-SPIRAP ≥95% |
905259 | Rh2(S-PTAD)4 |
905267 | (6- ≥95% |
905275 | (S,R,S)-AHPC-PEG6-butyl amine hydrochloride ≥95% |
905283 | (6- ≥95% |
905291 | Rh2(R-BTPCP)4 |
905313 | Rh2(S-TCPTAD)4 |
905321 | Rh2(R-TCPTAD)4 |
905348 | Rh2(R-p-Ph-TPCP)4 |
905356 | Rh2(R-PTAD)4 |
905380 | (S,R,S)-AHPC-C6-PEG3-butyl chloride ≥95% |